S-phase fraction and breast cancer--a decade of experience (Q33539158)

27 July 2017

1 reference

title

S-phase fraction and breast cancer--a decade of experience (English)

1 reference

27 July 2017

Wenger CR

1

1 reference

27 July 2017

Clark GM

series ordinal

2

1 reference

27 July 2017

language of work or name

English

0 references

publication date

1 January 1998

1 reference

Breast Cancer Research and Treatment

27 July 2017

published in

1 reference

27 July 2017

volume

51

1 reference

27 July 2017

issue

3

1 reference

27 July 2017

page(s)

255-265

1 reference

Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast. Report of the DNA Cytometry Consensus Conference.

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

Relationship between DNA ploidy and survival in patients with primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

Prognostic value of DNA ploidy and S-phase fraction in relation to estrogen receptor content and clinicopathological variables in primary breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

The prognostic significance of nuclear DNA content in invasive breast cancer--a study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

Proliferative activity, histological grade and benefit from adjuvant chemotherapy in node positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

DNA index, S-phase fraction, histological grade and prognosis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

Node-negative breast cancer: prognostic subgroups defined by tumor size and flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

The Stanford experience with high-dose etoposide cytoreductive regimens and autologous bone marrow transplantation in Hodgkin's disease and non-Hodgkin's lymphoma: preliminary data

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

Prognostic potential of flow cytometric S-phase and ploidy prospectively determined in primary breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

DNA flow cytometric analysis of primary operable breast cancer. Relation of ploidy and S-phase fraction to outcome of patients in NSABP B-04.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

The relationship between c-erbB-2 expression, S-phase fraction and prognosis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

Prognostic significance of S-phase fraction in good-risk, node-negative breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

Prognostic value of DNA flow cytometry in the locally recurrent, conservatively treated breast cancer patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

Aggressiveness of breast cancers found with and without screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

Significance of S-phase fraction and hormone receptor content in the management of young breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

Lack of prognostic significance of DNA ploidy and S phase fraction in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

Proliferating-cell nuclear antigen (PC10) immunolabelling and other proliferation indices as prognostic factors in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

S-phase fraction and nuclear size in long term prognosis of patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

DNA ploidy and S-phase fraction in medullary carcinoma of the breast--a flow cytometric analysis using archival material

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

Relationship of DNA ploidy and S-phase fraction to survival after first recurrence of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

S-phase fraction and survival benefit from adjuvant chemotherapy or radiotherapy of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

The prognostic significance of DNA flow cytometry in breast cancer: results from 881 patients treated in a single centre

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

Recurrence-free survival in breast cancer improved by adjuvant tamoxifen--especially for progesterone receptor positive tumors with a high proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

Do DNA ploidy and S-phase fraction in primary tumour predict the response to chemotherapy in metastatic breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

DNA aneuploidy in early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

Tumour heterogeneity of DNA cell cycle variables in breast cancer measured by flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

Sequential assessment of multidrug resistance phenotype and measurement of S-phase fraction as predictive markers of breast cancer response to neoadjuvant chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

S-phase fraction identifies high-risk subgroups among DNA-diploid breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

Prognostic impact of proliferation-associated factors MIB1 (Ki-67) and S-phase in node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

Prognostic and Predictive Factors for Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Adopted on May 17, 1996 by the American Society of Clinical Oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

7 January 2021

DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

7 January 2021

Improving the prognostic value of DNA flow cytometry in breast cancer by combining DNA index and S-phase fraction: A proposed classification of DNA histograms in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

7 January 2021

Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

7 January 2021

Cytometric characterization and clinical course of breast cancer diagnosed in a population-based screening program

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

7 January 2021

Indicators of prognosis in node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

7 January 2021

Long-term prognosis of scar and non-scar cancers of the breast

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

7 January 2021

The importance of DNA flow cytometry in node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

7 January 2021

Proliferation and DNA ploidy in malignant breast tumors in relation to early oral contraceptive use and early abortions

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

7 January 2021

Factors predicting late mortality from breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

7 January 2021

Image cytometric DNA analysis in human breast cancer analysis may add prognostic information in diploid cases with low S-phase fraction by flow cytometry

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

7 January 2021

DNA flow cytometry, nuclear morphometry, mitotic indices and steroid receptors as independent prognostic factors in female breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

7 January 2021

Flow cytometry DNA analysis and prediction of loco-regional recurrences after mastectomy in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

7 January 2021

Prognostic significance of flow cytometric DNA analysis and estrogen receptor content in breast carcinomas--a 10 year survival study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

7 January 2021

One or multiple samplings for flow cytometric DNA analyses in breast cancer-prognostic implications?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

7 January 2021

Effect of DNA ploidy classification on prognosis in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

7 January 2021

Identification of subgroups with favorable prognosis in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

7 January 2021

Prognostic factors in node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

7 January 2021

Interrelations between cellular DNA content, S-phase fraction, hormone receptor status and age in primary breast cancer. A series of 1,342 consecutively detected tumors. South-East Sweden Breast Cancer Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

7 January 2021

Relationships of DNA ploidy, S-phase fraction and hormone receptor status to tumor stage in breast cancers detected by population screening. The South-East Sweden Breast Cancer Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

7 January 2021

Markers of prognosis in breast cancer--the relationship between binding of the lectin HPA and histological grade, SPF, and ploidy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

7 January 2021

How to integrate steroid hormone receptor, flow cytometric, and other prognostic information in regard to primary breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

7 January 2021

DNA flow cytometry and pathologic grading as prognostic guides in axillary lymph node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

7 January 2021

S-phase fraction is a prognostic factor in stage I breast carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

7 January 2021

DNA ploidy, S-phase, and steroid receptors in more than 127,000 breast cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

7 January 2021

S-phase determination of immunoselected cytokeratin-containing breast cancer cells improves the prediction of recurrence

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

7 January 2021

Prediction of axillary lymph node metastases in a screened breast cancer population. South-East Sweden Breast Cancer Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

7 January 2021

Predictors of axillary lymph node metastases in patients with T1 breast cancer. A multivariate analysis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

7 January 2021

Cell kinetics in human breast cancer: comparison between the prognostic value of the cytofluorimetric S-phase fraction and that of the antibodies to Ki-67 and PCNA antigens detected by immunocytochemistry

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

7 January 2021

Prediction of axillary lymph node status in breast cancer patients by use of prognostic indicators

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

7 January 2021

Simultaneous analysis of c-erbB-2 expression and DNA content in breast cancer using flow cytometry

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

7 January 2021

S‐phase fraction after gating on epithelial cells predicts recurrence in node‐negative breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

7 January 2021

Proliferative indices and oncoprotein expression in benign and malignant breast biopsies

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

7 January 2021

Comparison of DNA Content, S-Phase Fraction, and Survival Between Medullary and Ductal Carcinoma of the Breast

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

7 January 2021

Determining factors which predict response to primary medical therapy in breast cancer using a single fine needle aspirate with immunocytochemical staining and flow cytometry

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

7 January 2021

Flow cytometry in node-positive breast cancer: cancer and leukemia group B protocol 8869

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

7 January 2021

c-erbB-2/neu protein expression, DNA ploidy and S phase in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

7 January 2021

Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

7 January 2021

Premenopausal node-negative breast cancer: may adjuvant chemotherapy be indicated by the analysis of nuclear DNA dynamics?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006188512927

7 January 2021

Identifiers

DOI

10.1023/A:1006188512927

1 reference

Dimensions Publication ID

27 July 2017

1005161847

0 references

1 reference